JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Prognostic value of the controlling nutritional status (CONUT) and the Prognostic Nutritional Index (PNI) scores in mycosis fungoides
Abstract
Aims: Mycosis fungoides (MF) is the most prevalent cutaneous T-cell lymphoma, exhibiting an indolent but potentially progressive course. Although the tumor-node-metastasis-blood (TNMB) system is the standard prognostic tool, survival outcomes vary among patients with the same stage, underscoring the need for complementary biomarkers. The Controlling Nutritional Status (CONUT) score and the Prognostic Nutritional Index (PNI) are composite indicators reflecting systemic nutritional and immune status. Their prognostic value has been established in hematologic malignancies, but their role in MF remains unclear. To evaluate the prognostic significance of CONUT and PNI scores in MF and to examine their associations with disease stage, inflammatory markers, and clinical progression. Methods: This retrospective study included 130 patients with histologically confirmed MF. Demographic, clinical, and laboratory parameters were collected at baseline. CONUT and PNI were calculated using serum albumin, total cholesterol, and lymphocyte count. Patients were classified into early (IA-IIA) and advanced (?IIB) stages per ISCL/EORTC criteria. Comparative analyses, Spearman correlations, ROC curve analyses, and multivariate logistic regressions were performed to determine predictive factors for advanced disease (p

Keywords : Mycosis fungoides, CONUT score, prognostic nutritional index, prognosis, cutaneous T-cell lymphoma

Download Article


1. Hodak E, Amitay-Laish I. Mycosis fungoides: a great imitator. Clin Dermatol. 2019 ;37(3):255-267. doi:10.1016/j.clindermatol.2019.01.004
2. Mourad A, Gniadecki R. Overall survival in mycosis fungoides: a systematic review and meta-analysis. J Invest Dermatol. 2020;140(2):495-497.e5. doi:10.1016/j.jid.2019.07.712
3. Larocca C, Kupper T. Mycosis fungoides and sézary syndrome: an update. Hematol Oncol Clin North Am. 2019;33(1):103-120. doi:10.1016/j.hoc.2018.09.001
4. Zhang Y, Chen Q, Lu C, Yu L. Prognostic role of controlling nutritional status score in hematological malignancies. Hematology. 2022;27(1):653-658. doi:10.1080/16078454.2022.2078040
5. Tiglioglu M, A Öztürk HB, Yıldız A, et al. The utility of CONUT score in indolent lymphoma patients. Niger J Clin Pract. 2023;26(9):1290-1296. doi:10.4103/njcp.njcp_20_23
6. Zuo J, Lei T, Zhong S, et al. C-reactive protein levels, the Prognostic Nutritional Index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients. Neurosurg Rev. 2023;47 (1):17. doi:10.1007/s10143-023-02248-1
7. Akgün Çağlıyan G, Hacıoğlu S, Ünver Koluman B, et al. Is CONUT score a Prognostic Index in patients with diffuse large cell lymphoma? Turk J Med Sci. 2021;51(4):2112-2119. doi:10.3906/sag-2101-406
8. Gürsoy V, Hunutlu FÇ, Pinar IE, et al. The clinical impacts of the controlling nutritional status score on patients with Hodgkin lymphoma. Eur Rev Med Pharmacol Sci. 2023;27(20):9916-9927. doi:10.26355/eurrev_202310_34170
9. Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H. Clinical impact of the CONUT score in patients with multiple myeloma. Ann Hematol. 2020;99(1):113-119. doi:10.1007/s00277-019-03 844-2
10. Zhao J, Wu Y. Prognostic value of the controlling nutritional status (CONUT) score in patients with diffuse large B-cell lymphoma: a meta-analysis. World J Surg Oncol. 2025;23(1):28. doi:10.1186/s12957-025-036 63-y
11. Ma S, Zhang B, Lu T, Li D, Li T, Shen. Huaihai lymphoma working group. value of the Prognostic Nutritional Index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: a multicenter retrospective study of the Huaihai Lymphoma Working Group. Cancer. 2022;128(19):3487-3494. doi:10.1002/cncr.34405
12. Lee SF, Ng TY, Wong FCS. The value of Prognostic Nutritional Index in follicular lymphoma. Am J Clin Oncol. 2019;42(2):202-207. doi:10.1097/COC.0000000000000493
13. Wang F, Lu L, Zang H, Yue Y, Cao Y, Chen M. Malnutrition defined by Controlling Nutritional Status score was independently associated with prognosis of diffuse large B-cell lymphoma primarily on elderly patients. Hematology. 2025;30(1):2434276. doi:10.1080/16078454.2024.2434276.
14. Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides, sézary syndrome, and cutaneous b-cell lymphomas: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2025;100(9):1603-1628. doi:10.1002/ajh.27735
15. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–22. doi:10.1182/blood-2007-03-055749
16. Go SI, Choi BH, Park MJ, et al. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell lymphoma. BMC Cancer. 2023;23(1):1071.
17. Matsukawa T, Suto K, Kanaya M, et al. North Japan Hematology Study Group (NJHSG). Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020;99(12): 2859-2868. doi: 10.1007/s00277-020-04262-5
18. Li L, Shou L. Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis. BMJ Open. 2024;14(3):e078320. doi:10.1136/bmjopen-2023-078320
19. Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. An externally validated nomogram for predicting the overall survival of patients with diffuse large B-cell lymphoma based on clinical characteristics and systemic inflammatory markers. Technol Cancer Res Treat. 2023;22:153303382311 80785. doi:10.1177/15330338231180785
20. Farabi B, Seminario-Vidal L, Jamgochian M, et al. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials. J Cosmet Dermatol. 2022;21(7):2742-2748. doi:10.1111/jocd.14528
21. Wu XB, Hou SL, Liu H. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients. World J Clin Cases. 2021;9(32):98 25-9834. doi:10.12998/wjcc.v9.i32.9825.
22. He J, Yin H, Xia Y, Wu JZ, Liang JH, Zhu HY. Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma. Leuk Res. 2021;110:106664. doi:10.1016/j.leukres.2021. 106664
Article available in :
Volume 9, Issue 1, 2026
Page : 71-77
https://doi.org/10.32322/jhsm.1814860
Article Information
Received : 31 Eki 2025
Accepted : 23 Kas 2025
Published : 05 Oca 2026
Corresponding Author :

Gökçe Işıl Kurmuş: Department of Dermatology and Venereology, Ankara Etlik City Hospital, Ankara, Turkiye

[email protected]
Citation : Işıl Kurmuş G, Yılmaz EB, Karataş H, Kartal SP. Prognostic value of the controlling nutritional status (CONUT) and the Prognostic Nutritional Index (PNI) scores in mycosis fungoides. J Health Sci Med. 2026;9(1):71-77. doi:10.32322/jhsm.1814860

Read: 81
Download : 145
Cited: 0
_Footer